The effect of saponins from Ampelozizyphus amazonicus Ducke on the renal Na+ pumps’ activities and urinary excretion of natriuretic peptides

BMC Complementary and Alternative Medicine

Maria Aparecida Ribeiro Vieira⁴  MariadasGraçasLins Brandão³  Adelina Martha dos Reis⁴  Geovanni Dantas Cassali¹  Celso Caruso-Neves²  Aloa Machado de Souza²  Flávia Magalhães Cardoso⁴  Viviane Gomes Portella⁴  Lúcio Ricardo Leite Diniz⁴ 

[1] Departamento de Patologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Belo Horizonte, Minas Gerais, 31270-901, Brazil;Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, CCS-Bloco G, Rio de Janeiro, 21949-900, Brazil;Laboratório de Pharmacognosia, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Belo Horizonte, Minas Gerais, 31270-901, Brazil;Departamento de Fisiologia e Biofísica, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Belo Horizonte, Minas Gerais, 31270-901, Brazil

关键词: atrial natriuretic peptides;    (Na⁺,K⁺)-ATPase;    Na⁺-ATPase;    antidiuresis;    saponins;    Rhamnaceae;    Ampelozizyphus amazonicus Ducke;   

Others  :  1232647
DOI  :  10.1186/1472-6882-12-40

 received in 2011-09-22, accepted in 2012-04-11,  发布年份 2012

【 摘 要 】

Background

In a previous study, we showed that a saponin mixture isolated from the roots of Ampelozizyphus amazonicus Ducke (SAPAaD) reduces urine excretion in rats that were given an oral loading of 0.9 % NaCl (4 ml/100 g body weight). In the present study, we investigated whether atrial natriuretic peptides (ANP) and renal ATPases play a role in the SAPAaD- induced antidiuresis in rats.

Methods

To evaluate the effect of SAPAaD on furosemide-induced diuresis, Wistar rats (250-300 g) were given an oral loading of physiological solution (0.9 % NaCl, 4 ml/100 g body weight) to impose a uniform water and salt state. The solution containing furosemide (Furo, 13 mg/kg) was given 30 min after rats were orally treated with 50 mg/kg SAPAaD (SAPAaD + Furo) or 0.5 ml of 0.9 % NaCl (NaCl + Furo). In the SAPAaD + NaCl group, rats were pretreated with SAPAaD and 30 min later they received the oral loading of physiological solution. Animals were individually housed in metabolic cages, and urine volume was measured every 30 min throughout the experiment (3 h). To investigate the role of ANP and renal Na⁺ pumps on antidiuretic effects promoted by SAPAaD, rats were given the physiological solution (as above) containing SAPAaD (50 mg/kg). After 90 min, samples of urine and blood from the last 30 min were collected. Kidneys and atria were also removed after previous anesthesia. ANP was measured by radioimmunoassay (RIA) and renal cortical activities of Na⁺- and (Na⁺,K⁺)-ATPases were calculated from the difference between the [³²P] Pi released in the absence and presence of 1 mM furosemide/2 mM ouabain and in the absence and presence of 1 mM ouabain, respectively.

Results

It was observed that SAPAaD inhibited furosemide-induced diuresis (at 90 min: from 10.0 ± 1.0 mL, NaCl + Furo group, n = 5, to 5.9 ± 1.0 mL, SAPAaD + Furo group n = 5, p < 0.05), increased both Na⁺-ATPase (from 25.0 ± 5.9 nmol Pi.mg^-1.min^-1, control, to 52.7 ± 8.9 nmol Pi.mg^-1.min^-1, p < 0.05) and (Na⁺,K⁺)-ATPase (from 47.8 ± 13.3 nmol Pi.mg^-1.min^-1, control, to 79.8 ± 6.9 nmol Pi .mg^-1.min^-1, p < 0.05) activities in the renal cortex. SAPAaD also lowered urine ANP (from 792 ± 132 pg/mL, control, to 299 ± 88 pg/mL, p < 0.01) and had no effect on plasma or atrial ANP.

Conclusion

We concluded that the SAPAaD antidiuretic effect may be due to an increase in the renal activities of Na⁺- and (Na⁺,K⁺)-ATPases and/or a decrease in the renal ANP.

【 授权许可】

   
2012 Diniz et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Wright CI, Van-Buren L, Kroner CI, Koning MM: Herbal medicines as diuretics: a review of the scientific evidence. J Ethnopharmacol 2007, 114(1):1-31.
• [2]Lahlou S, Tahraoui A, Israili Z, Lyoussi B: Diuretic activity of the aqueous extracts ofCarum carviand Tanacetum vulgare in normal rats. J Ethnopharmacol 2007, 110(3):458-463.
• [3]Haloui M, Louedec L, Michel JB, Lyoussi B: Experimental diuretic effects ofRosmarinus officinalisandCentaurium erythraea. J Ethnopharmacol 2000, 71(3):465-472.
• [4]Tahri A, Yamani S, Legssyer A, Aziz M, Mekhfi H, Bnouham M, Ziyyat A: Acute diuretic, natriuretic and hypotensive effects of a continuous perfusion of aqueous extract ofUrtica dioicain the rat. J Ethnopharmacol 2000, 73(1–2):95-100.
• [5]Ganapaty S, Dash GK, Subburaju T, Suresh P: Diuretic, laxative and toxicity studies ofCocculus hirsutusaerial parts. Fitoterapia 2002, 73(1):28-31.
• [6]Souza Santos AM, Kahwage CC, Coelho-Ferreira MR, Smpaio NA: Traditional medicines in the Rio Negro valley (Amazonas state, Brazil). Observation on the ethnopharmacology and the use of the plant Saracura-Mirá (Ampelozizyphus amazonicus): Pharmacological activity and/or symbolic efficacy. Bol. Mus. Para. Emílio Goeldi, sér. Ciências Humanas, Belém 2005, 1(1):137-147.
• [7]Coelho-Ferreira MR: Les Plantes Médicinales à Manaus: Utilisation et commercialisation. DESU de Biologie Végétale Tropicale. Paris, Université Paris VI,1992, p.60
• [8]Diniz LR, Santana PC, Ribeiro AP, Portella VG, Pacheco LF, Meyer NB, Cesar IC, Cosenza GP, Brandao MG, Vieira MA: Effect of triterpene saponins from roots ofAmpelozizyphus amazonicusDucke on diuresis in rats. J Ethnopharmacol 2009, 123(2):275-279.
• [9]Matsubara M: Renal sodium handling for body fluid maintenance and blood pressure regulation. Yakugaku Zasshi 2004, 124(6):301-309.
• [10]Stockand JD: Vasopressin regulation of renal sodium excretion. Kidney Int 2010, 78(9):849-856.
• [11]Proverbio F, Proverbio T, Marin R: Na + −ATPase is a different entity from the (Na++ K+)-ATPase in rat kidney basolateral plasma membranes. Biochim Biophys Acta 1986, 858(1):202-205.
• [12]Beltowski J, Wojcicka G: Regulation of renal tubular sodium transport by cardiac natriuretic peptides: two decades of research. Med Sci Monit 2002, 8(2):RA39-52.
• [13]Ewart HS, Klip A: Hormonal regulation of the Na(+)-K(+)-ATPase: mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol 1995, 269(2 Pt 1):C295-311.
• [14]Bestle MH, Bie P: Renal effects of urodilatin and atrial natriuretic peptide in volume expanded conscious dogs. Acta Physiol Scand 1993, 149(1):77-83.
• [15]Hildebrandt DA, Mizelle HL, Brands MW, Hall JE: Comparison of renal actions of urodilatin and atrial natriuretic peptide. Am J Physiol 1992, 262(3 Pt 2):R395-399.
• [16]Meyer M, Richter R, Brunkhorst R, Wrenger E, Schulz-Knappe P, Kist A, Mentz P, Brabant EG, Koch KM, Rechkemmer G, et al.: Urodilatin is involved in sodium homeostasis and exerts sodium-state-dependent natriuretic and diuretic effects. Am J Physiol 1996, 271(3 Pt 2):F489-497.
• [17]Feraille E, Doucet A: Sodium-potassium-adenosinetriphosphatase-dependent sodium transport in the kidney: hormonal control. Physiol Rev 2001, 81(1):345-418.
• [18]Lara Lda S, Cavalcante F, Axelband F, De Souza AM, Lopes AG, Caruso-Neves C: Involvement of the Gi/o/cGMP/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+−ATPase by Ang-(1–7). Biochem J 2006, 395(1):183-190.
• [19]Vives D, Farage S, Motta R, Lopes AG, Caruso-Neves C: Atrial natriuretic peptides and urodilatin modulate proximal tubule Na(+)-ATPase activity through activation of the NPR-A/cGMP/PKG pathway. Peptides 2010, 31(5):903-908.
• [20]Landgraf SS, Wengert M, Silva JS, Zapata-Sudo G, Sudo RT, Takiya CM, Pinheiro AA, Caruso-Neves C: Changes in angiotensin receptors expression play a pivotal role in the renal damage observed in spontaneously hypertensive rats. Am J Physiol Renal Physiol 2011, 300(2):F499-510.
• [21]Queiroz-Madeira EP, Lara LS, Wengert M, Landgraf SS, Libano-Soares JD, Zapata-Sudo G, Takiya CM, Gomes-Quintana E, Lopes AG, et al.: Na(+)-ATPase in spontaneous hypertensive rats: possible AT(1) receptor target in the development of hypertension. Biochim Biophys Acta, 2010, 1798(3):360-366.
• [22]Chiolero A, Maillard M, Nussberger J, Brunner HR, Burnier M: Proximal sodium reabsorption: An independent determinant of blood pressure response to salt. Hypertension 2000, 36(4):631-637.
• [23]Biollaz J, Waeber B, Diezi J, Burnier M, Brunner HR: Lithium infusion to study sodium handling in unanesthetized hypertensive rats. Hypertension 1986, 8(2):117-121.
• [24]de Souza AM: Lara Lda S, Previato JO, Lopes AG, Caruso-Neves C, da Silva BP, Parente JP: Modulation of sodium pumps by steroidal saponins. Z Naturforsch C 2004, 59(5–6):432-436.
• [25]Kreydiyyeh SI, Usta J: Diuretic effect and mechanism of action ofPetroselinum hortense. J Ethnopharmacol 2002, 79(3):353-357.
• [26]Grubmeyer C, Penefsky HS: The presence of two hydrolytic sites on beef heart mitochondrial adenosine triphosphatase. J Biol Chem 1981, 256(8):3718-3727.
• [27]Caruso-Neves C, Coelho-Souza SA, Vives D, Goes G, Lara LS, Lopes AG: Modulation of ouabain-insensitive Na(+)-ATPase activity in the renal proximal tubule by Mg(2+), MgATP and furosemide. Int J Biochem Cell Biol 2002, 34(12):1586-1593.
• [28]Marin R, Gomez DC, Rodriguez GA, Proverbio T, Proverbio F: Ouabain-insensitive, Na-ATPase activity in pure suspensions of rat kidney proximal tubules. FEBS Lett 1990, 269(1):77-78.
• [29]Gutkowska J, Thibault G, Januszewicz P, Cantin M, Genest J: Direct radioimmunoassay of atrial natriuretic factor. Biochem Biophys Res Commun 1984, 122(2):593-601.
• [30]Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
• [31]Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, Forssmann WG: Isolation and structural analysis of "urodilatin", a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr 1988, 66(17):752-759.
• [32]Gagelmann M, Hock D, Forssmann WG: Urodilatin (CDD/ANP-95-126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (alpha-hANP/CDD-99-126). FEBS Lett 1988, 233(2):249-254.
• [33]Abassi ZA, Tate J, Hunsberger S, Klein H, Trachewsky D, Keiser HR: Pharmacokinetics of ANF and urodilatin during cANF receptor blockade and neutral endopeptidase inhibition. Am J Physiol 1992, 263(5 Pt 1):E870-876.
• [34]Becker BN, Greene J, Evanson J, Chidsey G, Stone WJ: Ginseng-induced diuretic resistance. JAMA 1996, 276(8):606-607.
• [35]Bangham AD, Horne RW, Glauert AM, Dingle JT, Lucy JA: Action of saponin on biological cell membranes. Nature 1962, 196:952-955.
• [36]Foussard-Guilbert F, Ermias A, Laget P, Tanguy G, Girault M, Jallet P: Detergent effects of kinetic properties of (Na++ K+)-ATPase from kidney membranes. Biochim Biophys Acta 1982, 692:296-304.
• [37]Caruso-Neves C, Vives D, Dantas C, Albino CM, Fonseca LM, Lara LS, Iso M, Lopes AG: Ouabain-insensitive Na + −ATPase of proximal tubules is an effector for urodilatin and atrial natriuretic peptide. Biochim Biophys Acta 2004, 1660(1–2):93-98.
• [38]Citarella MR, Choi MR, Gironacci MM, Medici C, Correa AH, Fernandez BE: Urodilatin and dopamine: a new interaction in the kidney. Regul Pept 2009, 153(1–3):19-24.